Philanthropist Cynthia Lufkin is Elected to Nonprofit, The Breast Cancer Research Foundation, Board of Directors

NEW YORK--(Business Wire)--
Nonprofit, The Breast Cancer Research Foundation (BCRF), recently elected
philanthropist Cynthia Lufkin to its Board of Directors, following three years
of service on its Advisory Board. Ms. Lufkin graduated from Trinity College in
Hartford with a degree in biochemistry during which she was awarded a fellowship
in immunology from the University of Connecticut Medical School.

In conjunction with the Peter Jay Sharp Foundation, Ms. Lufkin has supported a
Breast Cancer Research Foundation-funded project at Memorial Sloan Kettering
Cancer Center on development of a DNA vaccine for breast cancer, vaccine
research led by Drs. Larry Norton and Alan Houghton.

Ms. Lufkin lives in Connecticut and New York City with her husband and three
children.

The Breast Cancer Research Foundation was founded in 1993 by Evelyn H. Lauder as
an independent, not-for-profit organization dedicated to funding innovative
clinical and translational research. In October 2009, nearly $29 million will
be awarded to 171 scientists across the United States, Canada, Latin America,
Europe, the Middle East, and Australia. BCRF perseveres in directing at least 85
cents of every dollar raised directly to research. And for the eighth
consecutive year, BCRF received Charity Navigator`s highest rating, four stars,
thus outperforming over 99.8% of the 5,400 evaluated charities, while the
American Institute of Philanthropy has awarded BCRF its highest possible rating
of A+. BCRF is the only breast cancer organization in the U.S. to receive these
accolades. For more information about BCRF, visit www.bcrfcure.org.

The Breast Cancer Research Foundation
Anna DeLuca, 646-497-2609
annadeluca@aol.com

Copyright Business Wire 2009